Rod Jackson Selected Research

Rod Jackson Research Topics

Disease

22	Cardiovascular Diseases (Cardiovascular Disease) 08/2022 - 10/2005
7	Acute Coronary Syndrome 01/2022 - 05/2014
7	Hypertension (High Blood Pressure) 01/2022 - 01/2005
5	Obesity 12/2021 - 10/2003
5	Hemorrhage 01/2021 - 01/2018
3	Myocardial Infarction 01/2022 - 05/2008
3	Stroke (Strokes) 01/2022 - 02/2015
3	Chronic Obstructive Pulmonary Disease (COPD) 11/2021 - 01/2021
3	Neoplasms (Cancer) 10/2019 - 03/2016
2	Heart Failure 09/2023 - 11/2022
2	Atrial Fibrillation 09/2023 - 10/2018
2	Coronary Disease (Coronary Heart Disease) 01/2022 - 06/2012
2	Heart Diseases (Heart Disease) 01/2020 - 05/2008
1	Chronic Renal Insufficiency 09/2023
1	Cerebrovascular Disorders (Cerebrovascular Occlusion) 01/2023
1	Ischemic Stroke 01/2022
1	Gout 01/2022
1	Injection Site Reaction 01/2022
1	Heart Arrest (Cardiac Arrest) 02/2020
1	Ventricular Tachycardia 02/2020
1	Cardiac Arrhythmias (Arrythmia) 02/2020
1	Chronic Disease (Chronic Diseases) 01/2020
1	Liver Diseases (Liver Disease) 01/2019
1	Peptic Ulcer (Peptic Ulcers) 01/2019
1	Chronic Pancreatitis 01/2019
1	Overweight 01/2014
1	Hypersensitivity (Allergy) 03/2011
1	Asthma (Bronchial Asthma) 03/2011
1	Wounds and Injuries (Trauma) 05/2004

Drug/Important Bio-Agent (IBA)

9	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2023 - 05/2008
8	CholesterolIBA 09/2023 - 01/2005
8	LipidsIBA 09/2021 - 04/2006
6	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 10/2019 - 01/2011
3	HDL CholesterolIBA 09/2023 - 01/2014
3	Bronchodilator Agents (Bronchodilators)IBA 01/2022 - 01/2021
3	Antihypertensive Agents (Antihypertensives)IBA 01/2022 - 02/2009
3	Glucose (Dextrose)FDA LinkGeneric 12/2021 - 04/2006
2	CreatinineIBA 09/2023 - 01/2022
2	omega-Chloroacetophenone (Mace)IBA 01/2022 - 01/2018
2	Uric Acid (Urate)IBA 01/2022 - 01/2013
2	AnticoagulantsIBA 01/2021 - 10/2018
2	Triglycerides (Triacylglycerol)IBA 01/2014 - 11/2008
2	CokeIBA 08/2013 - 10/2003
2	SugarsIBA 03/2011 - 10/2003
1	Neprilysin (Neutral Endopeptidase)IBA 11/2022
1	Mineralocorticoid Receptor AntagonistsIBA 11/2022
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 11/2022
1	Angiotensin Receptors (Angiotensin II Receptor)IBA 11/2022
1	Angiotensin Receptor AntagonistsIBA 11/2022
1	pro-brain natriuretic peptide (1-76)IBA 08/2022
1	TroponinIBA 08/2022
1	Vitamin D FDA LinkGeneric 08/2022
1	Biomarkers (Surrogate Marker)IBA 08/2022
1	Allopurinol (Remid)FDA LinkGeneric 01/2022
1	PCSK9 InhibitorsIBA 01/2022
1	Colchicine FDA LinkGeneric 01/2022
1	lipoprotein cholesterolIBA 01/2022
1	Ezetimibe (Zetia)FDA Link 01/2022
1	Muscarinic AntagonistsIBA 01/2021
1	CarcinogensIBA 01/2020
1	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2019
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 01/2019
1	Selective Serotonin Reuptake Inhibitors (Serotonin Reuptake Inhibitors)IBA 01/2019
1	Complement System Proteins (Complement)IBA 10/2018
1	Atorvastatin (Lipitor)FDA Link 10/2016
1	SolutionsIBA 01/2015
1	CoagulantsIBA 08/2014
1	LDL CholesterolIBA 08/2014
1	Hydrochlorothiazide (Esidrix)FDA LinkGeneric 01/2011
1	Lisinopril (Prinivil)FDA LinkGeneric 01/2011
1	Simvastatin (Zocor)FDA LinkGeneric 01/2011
1	SaltsIBA 02/2009
1	SmokeIBA 11/2008
1	Lipoproteins (Lipoprotein)IBA 04/2006
1	Blood Alcohol ContentIBA 05/2004

Therapy/Procedure

7	Therapeutics 11/2021 - 10/2005
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2018
2	Secondary Prevention 01/2022 - 02/2020
2	Percutaneous Coronary Intervention 09/2020 - 01/2019
1	Implantable Defibrillators (Implantable Cardioverter-Defibrillator) 11/2022
1	Injections 01/2022
1	Coronary Artery Bypass (Coronary Artery Bypass Surgery) 09/2020
1	Length of Stay 01/2020
1	Contraindications 10/2018